Dolby Laboratories (NYSE:DLB – Get Free Report) issued an update on its FY 2027 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 4.270-4.420 for the period, compared to the consensus earnings per share estimate of 4.340. The company issued revenue guidance of $1.4 billion, compared to the consensus revenue estimate of $1.5 billion. Dolby Laboratories also updated its Q1 2027 guidance to 0.410-0.560 EPS.
Analyst Ratings Changes
Several research firms recently issued reports on DLB. Zacks Research raised shares of Dolby Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, November 13th. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Weiss Ratings raised shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, September 9th. Finally, Rosenblatt Securities cut their target price on shares of Dolby Laboratories from $85.00 to $80.00 and set a “buy” rating on the stock in a research note on Monday. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $85.00.
Check Out Our Latest Analysis on Dolby Laboratories
Dolby Laboratories Price Performance
Shares of DLB opened at $58.60 on Wednesday. The business’s fifty day moving average price is $60.90 and its 200 day moving average price is $59.40. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $69.95. The stock has a market capitalization of $5.49 billion, a PE ratio of 24.94 and a beta of 0.79.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings data on Tuesday, November 17th. The electronics maker reported $1.25 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.05. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The firm had revenue of $373.54 million during the quarter, compared to the consensus estimate of $372.76 million. During the same quarter in the previous year, the company posted $0.99 earnings per share. The firm’s revenue was up 21.7% on a year-over-year basis. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. As a group, research analysts anticipate that Dolby Laboratories will post 3.23 earnings per share for the current fiscal year.
Dolby Laboratories Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 9th. Stockholders of record on Tuesday, December 1st will be given a $0.39 dividend. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Tuesday, December 1st. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.36. Dolby Laboratories’s payout ratio is 61.28%.
Dolby Laboratories declared that its board has approved a stock buyback plan on Thursday, July 30th that allows the company to repurchase $350 million in shares. This repurchase authorization allows the electronics maker to repurchase up to 7% of its stock through open market purchases. Share repurchase plans are generally an indication that the company’s management believes its stock is undervalued.
Insider Transactions at Dolby Laboratories
In other Dolby Laboratories news, SVP John D. Couling sold 7,667 shares of the firm’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $58.78, for a total value of $450,666.26. Following the transaction, the senior vice president owned 166,803 shares of the company’s stock, valued at $9,804,680.34. This trade represents a 4.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Ryan Nicholson sold 1,183 shares of the firm’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total transaction of $77,226.24. Following the completion of the transaction, the chief accounting officer directly owned 34,453 shares in the company, valued at $2,249,091.84. This represents a 3.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 16,517 shares of company stock valued at $995,963. Insiders own 37.93% of the company’s stock.
Recent Dolby Laboratories Headlines
These are some of the DLB headlines that stood out recently:
- Positive Sentiment: Fiscal Q4 revenue rose 21.7% year over year to about $374 million, slightly above estimates, while EPS of $1.25 beat the roughly $1.19–$1.20 consensus and increased from $0.99 a year earlier. Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2026 Financial Results
- Positive Sentiment: Dolby raised its quarterly dividend 8.3%, from $0.36 to $0.39 per share, equivalent to $1.56 annually and a stated yield of 2.7%. The dividend is payable December 9 to shareholders of record December 1.
- Negative Sentiment: Forward guidance was the main concern: Q1 fiscal 2027 revenue is forecast at $285–$305 million versus $358.3 million expected, and EPS at $0.41–$0.56 versus $1.06 expected. Fiscal 2027 revenue guidance of $1.4 billion also trails the $1.5 billion consensus. The full-year EPS range of $4.27–$4.42 is broadly in line with the $4.34 estimate, but the large Q1 shortfall may signal a softer near-term outlook. Dolby guidance and results
Dolby Laboratories Company Profile
Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.
Read More
- Five stocks we like better than Dolby Laboratories
- Disney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
